Recent FEMY News
- Femasys Announces Partnership with HRC Fertility, Esteemed Conglomerate Provider of Fertility Services in Western U.S., to Offer FemaSeed • GlobeNewswire Inc. • 12/03/2024 02:00:00 PM
- Femasys Announces Peer-Reviewed Publication of Positive Data from Prospective, Multicenter Pivotal Trial of FemaSeed® Infertility Treatment • GlobeNewswire Inc. • 11/26/2024 01:30:00 PM
- Form 8-K/A - Current report: [Amend] • Edgar (US Regulatory) • 11/12/2024 09:01:39 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/12/2024 01:51:12 PM
- Femasys Announces Financial Results for Quarter Ended September 30, 2024, and Provides Corporate Update • GlobeNewswire Inc. • 11/12/2024 01:30:00 PM
- Femasys to Exhibit at the Annual AAGL 2024 Global Conference • GlobeNewswire Inc. • 11/07/2024 01:30:00 PM
- Femasys Announces Issued U.S. Patent Covering FemBloc® Device for Female Permanent Birth Control • GlobeNewswire Inc. • 11/01/2024 12:30:00 PM
- Femasys Announces Partnership with Boston IVF, Prominent Network of Fertility Centers, to Offer FemaSeed • GlobeNewswire Inc. • 10/30/2024 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/29/2024 12:30:58 PM
- Femasys to Exhibit at ASRM 2024 and Participate in the Congress’ KEEPR Education Program • GlobeNewswire Inc. • 10/10/2024 12:30:00 PM
- Femasys to Participate in a Fireside Chat at the 2024 Maxim Healthcare Virtual Summit • GlobeNewswire Inc. • 10/08/2024 12:30:00 PM
- Femasys Receives Second Order from Spain Partners After Successfully Completing Commercial FemaSeed® Infertility Treatments • GlobeNewswire Inc. • 10/02/2024 12:30:00 PM
- Femasys Announces Infertility Clinic Customers from Coast to Coast • GlobeNewswire Inc. • 09/18/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/11/2024 12:38:07 PM
- Femasys Secures Strategic Distribution Partnerships for Commercialization of FemaSeed® for over $1.3M in Spanish Market • GlobeNewswire Inc. • 09/11/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 09/09/2024 12:45:27 PM
- Femasys Inc. Receives U.S. FDA Clearance to Market FemChec®, an Innovative Diagnostic Solution for Fallopian Tube Check • GlobeNewswire Inc. • 09/09/2024 12:30:00 PM
- Femasys to Exhibit at The Canadian Fertility and Andrology Society’s 70th Annual Meeting • GlobeNewswire Inc. • 09/05/2024 12:30:00 PM
- Femasys to Participate in Fireside Chat at the H.C. Wainwright 26th Annual Global Investment Conference • GlobeNewswire Inc. • 09/03/2024 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/30/2024 08:31:59 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/29/2024 01:15:35 PM
- Femasys Announces CE Mark and Canadian Approval for FemVue® MINI, a Fallopian Tube Assessment Solution • GlobeNewswire Inc. • 08/29/2024 12:30:00 PM
- Femasys Hosts Congresswoman Lucy McBath at Georgia Headquarters • GlobeNewswire Inc. • 08/27/2024 12:30:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/08/2024 12:45:36 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 08/08/2024 12:35:40 PM
UAV Corp Skyborne Technology Secures $105M in Sales Contract LOIs for Revolutionary DART Series Airships • UMAV • Jan 13, 2025 11:00 AM
SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) • SNWV • Jan 13, 2025 8:10 AM
SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales • SNWV • Jan 13, 2025 8:08 AM
North Bay Resources Announces Operation of New Gravity Circuit at Bishop Gold Mill, California • NBRI • Jan 10, 2025 8:29 AM
Cannabix Technologies Announces Key Hardware Advancements to Marijuana Breathalyzer Technology • BLO • Jan 9, 2025 8:49 AM
UAV Corp. (UMAV) Further Reduces Authorized Shares to 500 Million • UMAV • Jan 8, 2025 2:27 PM